Form D · Pharmaceuticals
Coeptis Therapeutics Holdings, Inc.
Wexford, PA · CIK 0001759186
Offering snapshot reported Aug 7, 2025 · SEC filing
- Reported sold
- $4M Offering amount: $5M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Jul 24, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 7, 2025 | Initial | $4,000,000 | No comparison | 9 | SEC filing |
| Jun 27, 2024 | Initial | $4,300,000 | No comparison | 7 | SEC filing |
| Nov 3, 2023 | Initial | $2,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-553921
Source: Form D, filed Aug 7, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Christopher Calise | Director |
| Christopher Cochran | Director |
| Brian Cogley | Executive |
| Colleen Delaney | Executive |
| Philippe Deschamps | Director |
| Tara Maria De Silva | Director |
| David Mehalick | Director, Executive |
| Gene Salkind | Director |
| Christine Sheehy | Executive |
| Daniel Yerace | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
105 Bradford Road Suite 420
Wexford, PA, 15090
Phone: 724-934-6467
Wexford, PA, 15090
Phone: 724-934-6467